The extraction of nucleic acids is the primary step in numerous research and therapeutic applications. The development of personalized medicine is another major factor that boosts revenue generation in the market. It has been witnessed that the kits and reagents segment dominated the market in 2020 and resulted in a large revenue share.
According to Data Bridge Market Research, the Global Automated Nucleic Acid Extraction Devices Market, which is USD 4.7 billion in 2022, is expected to reach USD 11.15 billion by 2030, at a CAGR of 11.4% during the forecast period 2023 to 2030.
" High Usage in DNA Isolation and Purification Surge the Market Growth"
There is an increasing use of automated nucleic acid extraction devices in DNA isolation and purification which is expected to increase the market growth due to its growing application in gene expression profiling. In addition, pharmaceutical and biotechnology companies are undertaking numerous strategic initiatives, such as the launch of new products for efficiently carrying out nucleic acid isolation steps. For instance, Promega Corporation launched its Wizard HMW DNA Extraction Kit in 2020. The kit assisted the scientists in working with large DNA fragments, enabling steady performance during long-read sequencing applications. Thus, this factor boosts market growth.
What restraints the growth of the Global Automated Nucleic Acid Extraction Devices Market?
" Lack of Skilled Professionals"
There is a shortage of healthcare professionals that deal with automated nucleic acid extraction devices. Not all people know these devices. In developing and underdeveloped countries, research institutes and hospitals do not have professionals with the proper knowledge to work with these devices for carrying out genetic experiments. All these major factors impede the growth of the market.
Segmentation: Global Automated Nucleic Acid Extraction Devices Market
The global automated nucleic acid extraction devices market is segmented on the basis of product, type, end-user.
- On the basis of product, the automated nucleic acid extraction devices market is segmented into fully automated, semi-automated.
- Based on the type, the automated nucleic acid extraction devices market is segmented into instruments, kits and consumables.
- Based on the end user, the automated nucleic acid extraction devices market is segmented into hospitals, diagnostic centers, forensic laboratories, pharmaceutical and biotechnology companies, academic research institutes
Regional Insights: North America is expected to dominate the Global Automated Nucleic Acid Extraction Devices Market
North America dominates the market due to the wide presence of established market players and their constant efforts in manufacturing technologically advanced rapid purification and isolation devices, which is the major contributor to market growth in this region. In addition, the increasing funding initiatives for biotechnology research activities are further boosting the market's growth in the region.
Asia-Pacific is expected to grow in the forecast period of 2023-2030 due to increasing economic growth, widespread research in life sciences, increasing patient population, supportive government initiatives, and the huge presence of numerous innovative biotech companies in the region. Also, increasing the incidence of genetic disorders is leading to market growth.
To know more about the study, visit, https://www.databridgemarketresearch.com/es/reports/global-automated-nucleic-acid-extraction-devices-market
Recent Developments in Global Automated Nucleic Acid Extraction Devices Market
- In 2022, Purigen launched Ionic Cells to Pure DNA Low Input Kit for scientists working with limited biological samples. The simplified and automated 60-minute workflow offers high-quality DNA to investigate genetic abnormalities or examine disease treatment effects quickly.
- In 2022, Qiagen Inc. launched NeuMoDxHSV 1/2 Quant Assay to quantify and differentiate herpes simplex virus type 1 (HSV-1) DNA and herpes simplex virus type 2 (HSV-2) with approval from the European Commission. It will let the company increase its product portfolio in laboratory testing, which will further lead to market growth due to the innovative tests
The Prominent Key Players Operating in the Global Automated Nucleic Acid Extraction Devices Market Include:
- QIAGEN (Germany)
- F. Hoffmann-La Roche Ltd (U.S.)
- Analytik Jena GmbH+Co. K.G. (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- AccuBioMed Co., Ltd. (Taiwan)
- AUTOGEN INC. (U.S.)
- Bioneer Corporation (South Korea)
- Illumina, Inc. (U.S.)
- Tecan Trading AG (Switzerland)
- Merck KGaA (Germany)
- B.D. (U.S.)
- PerkinElmer, Inc. (U.S.)
- DiaSorin S.p.A (Italy)
- Diagcor Bioscience Incorporation Limited (China)
Above are the key players covered in the report, to know about more and exhaustive list of global automated nucleic acid extraction devices market companies contact, https://www.databridgemarketresearch.com/es/contact
Research Methodology: Global Automated Nucleic Acid Extraction Devices Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
